Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Riker

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Surgical Case Reports|August 19, 2016
Neglected skin cancer in the elderly: a case of basosquamous cell carcinoma of the right shoulderErika Bisgaard, Michael Tarakji, Frank Lau, et al.
The Breast Journal|May 6, 2004
Comment on Rahusen et alElisabeth L Dupont, Charles E Cox, Adam Riker, et al.
Cancer Immunology, Immunotherapy : CII|November 30, 2005
Induction of anti-tumor immunity by vaccination with dendritic cells pulsed with anti-CD44 IgG opsonized tumor cellsShari Pilon-Thomas, Monique Verhaegen, Lisa Kuhn, et al.
American Journal of Surgery|December 19, 2002
Open Roux-en-Y gastric bypass for the morbidly obese in the era of laparoscopyRishindra M Reddy, Adam Riker, Deborah Marra, et al.
Molecular Cancer Therapeutics|December 19, 2006
Association of insulin-like growth factor binding protein-3 expression with melanoma progressionYaguang Xi, Go Nakajima, Tray Hamil, et al.
Cancer Research|September 3, 2010
Amplifying TLR-MyD88 signals within tumor-specific T cells enhances antitumor activity to suboptimal levels of weakly immunogenic tumor antigensDegui Geng, Liqin Zheng, Ratika Srivastava, et al.
Cancer Genomics & Proteomics|March 25, 2008
Global comparative gene expression analysis of melanoma patient samples, derived cell lines and corresponding tumor xenograftsYaguang Xi, Adam Riker, Lalita Shevde-Samant, et al.
Journal for Immunotherapy of Cancer|April 21, 2021
Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinomaPaul Nghiem, Shailender Bhatia, Evan J Lipson, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Surgical Case Reports|August 19, 2016
Neglected skin cancer in the elderly: a case of basosquamous cell carcinoma of the right shoulderErika Bisgaard, Michael Tarakji, Frank Lau, et al.
The Breast Journal|May 6, 2004
Comment on Rahusen et alElisabeth L Dupont, Charles E Cox, Adam Riker, et al.
Cancer Immunology, Immunotherapy : CII|November 30, 2005
Induction of anti-tumor immunity by vaccination with dendritic cells pulsed with anti-CD44 IgG opsonized tumor cellsShari Pilon-Thomas, Monique Verhaegen, Lisa Kuhn, et al.
American Journal of Surgery|December 19, 2002
Open Roux-en-Y gastric bypass for the morbidly obese in the era of laparoscopyRishindra M Reddy, Adam Riker, Deborah Marra, et al.
Molecular Cancer Therapeutics|December 19, 2006
Association of insulin-like growth factor binding protein-3 expression with melanoma progressionYaguang Xi, Go Nakajima, Tray Hamil, et al.
Cancer Research|September 3, 2010
Amplifying TLR-MyD88 signals within tumor-specific T cells enhances antitumor activity to suboptimal levels of weakly immunogenic tumor antigensDegui Geng, Liqin Zheng, Ratika Srivastava, et al.
Cancer Genomics & Proteomics|March 25, 2008
Global comparative gene expression analysis of melanoma patient samples, derived cell lines and corresponding tumor xenograftsYaguang Xi, Adam Riker, Lalita Shevde-Samant, et al.
Journal for Immunotherapy of Cancer|April 21, 2021
Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinomaPaul Nghiem, Shailender Bhatia, Evan J Lipson, et al.
Pageof 1